Asarina Pharma Investors

28 investors on Angel Roster list Asarina Pharma in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in France, the United States and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name Asarina Pharma can appear together.

Investors listed
28
With verified email
36%
Most common stage
Seed
Top location
France

Updated October 13, 2026 · How we compile this data

Top 28 Asarina Pharma investors

The most complete profiles first. Showing 28 of 28.

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Bao DinhVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Christophe SimonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Eric GallerneVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Luc MaruendaVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Matthieu BaretVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas DebockVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas NedelecVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Robin RivatonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Annette Fainbloom

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Matthieu B.

    Venture Capital, Private Equity Firm, Investor · France

    SeedPre-SeedHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Nicolas de Loiray

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Steven WrightVerified

    Venture Capital · United States

    Health CareBiotechnologyClinical TrialsHealth Diagnostics

    Portfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more

    Verified email available

  • Thomas WrightVerified

    Venture Capital · United States

    Health CareBiotechnologyClinical TrialsHealth Diagnostics

    Portfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more

    Verified email available

  • Daniel Emersleben

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Florian Zimmermann

    Private Equity Firm · Germany

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Jean Plamondon

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Nicolas Chaudron

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Thierry Legeais

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • George Elish

    Venture Capital · United States

    Health CareBiotechnologyClinical TrialsHealth Diagnostics

    Portfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more

    Contact details available

  • Jonathan Hepple

    Venture Capital · United Kingdom

    Health CareBiotechnologyClinical TrialsHealth Diagnostics

    Portfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more

    Contact details available

  • Laurie Dunk

    Venture Capital · Canada

    Health CareInvestment ManagementBiotechnologyClinical Trials

    Portfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more

    Contact details available

Frequently asked questions

How many Asarina Pharma investors are on Angel Roster?

Angel Roster lists 28 Asarina Pharma investors. 10 of them (36%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (21) and Venture Capital Firms (15). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Asarina Pharma investors invest in?

Among those that list a stage, the most common are Seed (7), Series B (2) and Pre-Seed (1).

Where are Asarina Pharma investors based?

Most are based in France (20), the United States (3) and Germany (2).

Which companies have Asarina Pharma investors backed?

The most-backed portfolio companies among them are FeetMe (23), DNA Script (23), Tacalyx (23), Corlieve Therapeutics (23) and Pharvaris (23).

How do I contact Asarina Pharma investors?

Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.